Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 55nM ΔG°: -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair